ICO
Closing Date:

Differentiated Solutions for Long-term Resolution of Chronic Autoimmunity

Differentiated Solutions for Long-term Resolution of Chronic Autoimmunity

A multinational biopharmaceutical company, with a long‑standing presence in rheumatology, immuno‑dermatology, bone disorders and neurological conditions, such as epilepsy, is now expanding their well-established activities in the immunology therapeutic area, with an ambition to bring transformational change to patients across priority disease indications focused on autoimmunity. This company is actively seeking approaches with potential for resolution and/or “reset” of the immune system with the potential to achieve long‑term disease and drug‑free remission...

To see the full details and submit your response please register now

Benefits of registration:

  • Receive updates on the latest industry calls
  • Quickly and easily respond to calls via your dashboard
  • Build your academic profile

Opportunity types being sought:

  • Technology
  • Academic Researcher
  • Centre of Excellence
  • Research Project
  • Spinout Company

Essential information:

Submission form:

Register Now

Share this call with professional partners:

An online matchmaking platform for university-industry collaboration. Learn More

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.